Adam Hansard - 13 Apr 2022 Form 4 Insider Report for Applied Therapeutics Inc. (APLT)

Role: Chief Commercial Officer
Signature: /s/ Shoshana Shendelman as attorney-in-fact
Issuer symbol: APLT
Transactions as of: 13 Apr 2022
Net transactions value: $0
Form type: 4
Filing time: 15 Apr 2022, 19:07:44 UTC
Previous filing: 11 Jan 2022
Next filing: 04 Aug 2022
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	APLT	Employee Stock Option (Right to Buy)	Award	$0	+50,000		$0.000000	50,000	13 Apr 2022	Common Stock	50,000	$2.02	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Consists of compensatory Options granted under Applied Therapeutics, Inc.'s 2019 Equity Incentive Plan. One-fourth (1/4th) of the shares subject to the compensatory Option shall vest on April 13, 2023, and one thirty-sixth (1/36th) of the remaining shares subject to the compensatory Option shall vest each month thereafter, subject to the Reporting Person continuing to provide services through each such date.

Content

Consists of compensatory Options granted under Applied Therapeutics, Inc.'s 2019 Equity Incentive Plan. One-fourth (1/4th) of the shares subject to the compensatory Option shall vest on April 13, 2023, and one thirty-sixth (1/36th) of the remaining shares subject to the compensatory Option shall vest each month thereafter, subject to the Reporting Person continuing to provide services through each such date.